Methods of treating musculodegenerative disease with an antibody that binds growth differentiation factor-8
US7534432B2 · kind B2 · utility
36Cited by
9References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 29, 2007 |
| Grant date | May 19, 2009 |
| Priority date | — |
| Expiry date | Feb 8, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/22
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Growth differentiation factor-8 (GDF-8) is disclosed along with its polynucleotide sequence and amino acid sequence. Also disclosed are diagnostic and therapeutic methods of using the GDF-8 polypeptide and polynucleotide sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.